Clinical Trial Update: The Efficacy and Safety of PEG-rhG-CSF（Pegylated Recombinant Human Granulocyte Colony Stimulating Factor)in Patients With Breast Cancer Who Were Treated With Intensive Chemotherapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the efficacy and safety of PEG-rhG-CSF in breast cancer patients receiving intensive chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• PEG-rhG-CSF (pegylated recombinant human granulocyte colony-stimulating factor)

Snippet

Sponsor: Peking University | Conditions: Breastcancer | Phase 4 | Status: COMPLETED